Published in Vaccine Weekly, May 18th, 2005
According to a study from Brazil, "The severity of varicella-zoster virus (VZV) in immunocompromised children, especially in those receiving renal transplants, is well known. However, the use of live attenuated virus vaccine in this population is controversial. This study aimed to: assess the immunization status of pediatric renal transplant recipients at our center; determine the anti-VZV antibody titers in such patients; evaluate the response to VZV vaccine in seronegative children and in those who present low antibody titers (defined as <500 mAU/mL)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly